With Pfizer’s stock down sharply, an activist investor is pushing for CEO Albert Bourla to improve performance.

Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the company.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter ...

News about Albert Bourla. Commentary and archival information about Albert Bourla from The New York Times.

Today, the case returns to the Belgian courts, but the lingering questions remain: Who is the man behind Pfizergate, and what really happened? We spoke with Clara Bauer-Babef, Euractiv’s health ...

When Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. But COVID-19 delayed those plans when Bourla ...

In a difficult year for Pfizer, in which its share price fell by 44%, CEO Albert Bourla’s compensation fell by 35%, from $33M to $21.6M in 2023.

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourla is the worst.

Pfizer CEO Albert Bourla posted the image on X, formerly Twitter, on Nov. 9. However, Bourla's post clearly states the image was taken "three years ago today," referring to Nov. 9, 2020.

Pfizer chairman and CEO Albert Bourla discusses the path ahead for the company, including its plans for acquisitions. He speaks with Bloomberg Wall Street Week host David Westin.

Based on our research, we rate FALSE the claim that Bourla is resigning and "admits" mRNA vaccines are unsafe. Bourla remains the CEO and chairman of Pfizer and has not announced any plans to resign.

A clip of an old interview showing Pfizer CEO Albert Bourla talking about the U.S. Food and Drug Administration’s approval of the company’s COVID-19 vaccine is circulating on social media.